Surgical Adhesion Barriers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Surgical Adhesion Barriers Pipeline Market Report Overview

Adhesions are bands of scar-like tissue that form abnormal fibrous connections joining tissue surfaces in abnormal locations. Generally, any type of transperitoneal operation can lead to the formation of adhesions ranging from minimal scarring of the serosal surface to firm agglutination of nearly all structures. However, post-surgical adhesion has a considerable epidemiological and clinical impact mostly due to tissue damage caused by surgical traumas.

The surgical adhesion barriers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·        Gel Surgical Adhesion Barriers

·        Membrane Surgical Adhesion Barriers

Key Territories ·        The United States

·        Europe

·        Japan

·        Singapore

·        Taiwan

Key Regulatory Paths ·        510(k)

·        CE

·        HSA

·        BOPA

·        PMA

Leading Companies ·        Actamax Surgical Materials LLC

·        Alafair Biosciences Inc

·        Anika Therapeutics Inc

·        ARC Medical Devices Inc

·        ARC Medical Inc.

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Surgical Adhesion Barriers Pipeline Market by Segments

The key segments of the surgical adhesion barriers pipeline market are gel surgical adhesion barriers and membrane surgical adhesion barriers. As of October 2024, gel surgical adhesion barriers accounted for the highest share of pipeline products.

Surgical Adhesion Barriers Pipeline Market Analysis by Segments, 2024 (%)

Surgical Adhesion Barriers Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Surgical Adhesion Barriers Pipeline Market

Download a Free Report Sample

Surgical Adhesion Barriers Pipeline Market Segmentation by Territories

A few of the key territories in the surgical adhesion barriers pipeline market are the US, Europe, Japan, Singapore, and Taiwan. As of October 2024, the US accounted for the most pipeline products.

Surgical Adhesion Barriers Pipeline Market Analysis by Territories, 2024 (%)

Surgical Adhesion Barriers Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Surgical Adhesion Barriers Pipeline Market

Download a Free Report Sample

Surgical Adhesion Barriers Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the surgical adhesion barriers pipeline products market are 510(k), CE, HAS, BOPA, and PMA. As of October 2024, 510(k) was the most followed pathway for pipeline products in the surgical adhesion barriers market.

Surgical Adhesion Barriers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Surgical Adhesion Barriers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Surgical Adhesion Barriers Pipeline Market, Download a Free Report Sample

Surgical Adhesion Barriers Pipeline Market – Competitive Landscape

A few of the key companies associated with the surgical adhesion barriers pipeline market are Actamax Surgical Materials LLC, Alafair Biosciences Inc, Anika Therapeutics Inc, ARC Medical Devices Inc, ARC Medical Inc., and others.

Alafair Biosciences Inc:  Headquartered in Austin, Texas, the US, Alafair Biosciences Inc. is a medical device company. It develops and commercializes surgical products for soft tissue repair and protection applications. The company develops products based on a non-cell adhesive hydrogel technology to protect and manage advanced wound healing.  

Anika Therapeutics Inc: Headquartered in Bedford, Massachusetts, the US, Anika Therapeutics Inc develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical, and veterinary applications.

Surgical Adhesion Barriers Pipeline Market Analysis by Companies, 2024

Surgical Adhesion Barriers Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Surgical Adhesion Barriers Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Surgical Adhesion Barriers Pipeline Market Segments Outlook (2024)

  • Gel Surgical Adhesion Barriers
  • Membrane Surgical Adhesion Barriers

Surgical Adhesion Barriers Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • Japan
  • Singapore
  • Taiwan

Surgical Adhesion Barriers Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • HSA
  • BOPA
  • PMA

Scope

This report provides:

  • Extensive coverage of the surgical adhesion barriers under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of surgical adhesion barriers and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of surgical adhesion barriers under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Actamax Surgical Materials LLC
Alafair Biosciences Inc
Anika Therapeutics Inc
ARC Medical Devices Inc
ARC Medical Inc.
Baxter International Inc
BioActive Polymers in Lund AB
Dalim Tissen Co Ltd
Duke University
FzioMed Inc
Genzyme Corp
HydroGlaze BV
Innocoll Technologies Ltd (Inactive)
Jinwoo Bio Co Ltd
Kytogenics Pharmaceuticals Inc
Leader Biomedical Europe BV
Luna Innovations Inc
Magen OrthoMed Ltd
Maxigen Biotech Inc
Medisse BV (Inactive)
MLM Biologics Inc
PolyNovo Biomaterials Pty Ltd
Rutgers The State University of New Jersey
Seikagaku Corp
Sporogenics Pte Ltd
Stony Brook University
Toray Medical Co Ltd
Tribos LLC
TYBR Health Inc
University of North Carolina at Chapel Hill

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Surgical Adhesion Barriers Overview

3 Products under Development

3.1 Surgical Adhesion Barriers – Pipeline Products by Stage of Development

3.2 Surgical Adhesion Barriers – Pipeline Products by Segment

3.3 Surgical Adhesion Barriers – Pipeline Products by Territory

3.4 Surgical Adhesion Barriers – Pipeline Products by Regulatory Path

3.5 Surgical Adhesion Barriers – Pipeline Products by Estimated Approval Date

3.6 Surgical Adhesion Barriers – Ongoing Clinical Trials

4 Surgical Adhesion Barriers – Pipeline Products under Development by Companies

4.1 Surgical Adhesion Barriers Companies – Pipeline Products by Stage of Development

4.2 Surgical Adhesion Barriers – Pipeline Products by Stage of Development

5 Surgical Adhesion Barriers Companies and Product Overview

5.1 Actamax Surgical Materials LLC Company Overview

5.1.1 Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview

5.2 Alafair Biosciences Inc Company Overview

5.2.1 Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 Anika Therapeutics Inc Company Overview

5.3.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.4 ARC Medical Devices Inc Company Overview

5.4.1 ARC Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 ARC Medical Inc. Company Overview

5.5.1 ARC Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.6 Baxter International Inc Company Overview

5.6.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 BioActive Polymers in Lund AB Company Overview

5.7.1 BioActive Polymers in Lund AB Pipeline Products & Ongoing Clinical Trials Overview

5.8 Dalim Tissen Co Ltd Company Overview

5.8.1 Dalim Tissen Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.9 Duke University Company Overview

5.9.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview

5.10 FzioMed Inc Company Overview

5.10.1 FzioMed Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 Genzyme Corp Company Overview

5.11.1 Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview

5.12 HydroGlaze BV Company Overview

5.12.1 HydroGlaze BV Pipeline Products & Ongoing Clinical Trials Overview

5.13 Innocoll Technologies Ltd (Inactive) Company Overview

5.13.1 Innocoll Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.14 Jinwoo Bio Co Ltd Company Overview

5.14.1 Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.15 Kytogenics Pharmaceuticals Inc Company Overview

5.15.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.16 Leader Biomedical Europe BV Company Overview

5.16.1 Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview

5.17 Luna Innovations Inc Company Overview

5.17.1 Luna Innovations Inc Pipeline Products & Ongoing Clinical Trials Overview

5.18 Magen OrthoMed Ltd Company Overview

5.18.1 Magen OrthoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.19 Maxigen Biotech Inc Company Overview

5.19.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.20 Medisse BV (Inactive) Company Overview

5.20.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.21 MLM Biologics Inc Company Overview

5.21.1 MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.22 PolyNovo Biomaterials Pty Ltd Company Overview

5.22.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.23 Rutgers The State University of New Jersey Company Overview

5.23.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview

5.24 Seikagaku Corp Company Overview

5.24.1 Seikagaku Corp Pipeline Products & Ongoing Clinical Trials Overview

5.25 Sporogenics Pte Ltd Company Overview

5.25.1 Sporogenics Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.26 Stony Brook University Company Overview

5.26.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview

5.27 Toray Medical Co Ltd Company Overview

5.27.1 Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.28 Tribos LLC Company Overview

5.28.1 Tribos LLC Pipeline Products & Ongoing Clinical Trials Overview

5.29 TYBR Health Inc Company Overview

5.29.1 TYBR Health Inc Pipeline Products & Ongoing Clinical Trials Overview

5.30 University of North Carolina at Chapel Hill Company Overview

5.30.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview

6 Surgical Adhesion Barriers- Recent Developments

6.1 Jun 17, 2024: FzioMed to Highlight its Adhesion Barrier Product Solutions at the Federation of European Societies for the Surgery of the Hand (FESSH) Congress

6.2 Apr 16, 2024: FzioMed to Showcase its Women’s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Surgical Adhesion Barriers – Pipeline Products by Stage of Development

Surgical Adhesion Barriers – Pipeline Products by Segment

Surgical Adhesion Barriers – Pipeline Products by Territory

Surgical Adhesion Barriers – Pipeline Products by Regulatory Path

Surgical Adhesion Barriers – Pipeline Products by Estimated Approval Date

Surgical Adhesion Barriers – Ongoing Clinical Trials

Surgical Adhesion Barriers Companies – Pipeline Products by Stage of Development

Surgical Adhesion Barriers – Pipeline Products by Stage of Development

Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview

Actamax Adhesion Barrier – Product Status

Actamax Adhesion Barrier – Product Description

Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

VersaWrap Adhesion Barrier – Product Status

VersaWrap Adhesion Barrier – Product Description

Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

HYAFF Gel – Product Status

HYAFF Gel – Product Description

ARC Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview

Discrete – Product Status

Discrete – Product Description

ARC Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview

Fluid Medical Device – Spine Surgeries – Product Status

Fluid Medical Device – Spine Surgeries – Product Description

JOCOAT – Product Status

JOCOAT – Product Description

TENCOAT – Product Status

TENCOAT – Product Description

Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview

ACCUREACH – Product Status

ACCUREACH – Product Description

SEPRALAP – Product Status

SEPRALAP – Product Description

BioActive Polymers in Lund AB Pipeline Products & Ongoing Clinical Trials Overview

BioBarrier – Product Status

BioBarrier – Product Description

Dalim Tissen Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Collabarrier Anti-Adhesion Coating Material – Product Status

Collabarrier Anti-Adhesion Coating Material – Product Description

Dalim Tissen Co Ltd – Ongoing Clinical Trials Overview

Collabarrier Anti-Adhesion Coating Material – A Clinical Study of the Safety and Effectiveness of Ionized Atelocollagen Based Adhesion barrier(Collabarrier) for Adhesion Prevention in Spine Surgery

Duke University Pipeline Products & Ongoing Clinical Trials Overview

Intrauterine Adhesion Barrier – Product Status

Intrauterine Adhesion Barrier – Product Description

FzioMed Inc Pipeline Products & Ongoing Clinical Trials Overview

Oxiplex/AP – Product Status

Oxiplex/AP – Product Description

Oxiplex/IU – Product Status

Oxiplex/IU – Product Description

Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview

Sepraspray Adhesion Barrier – Product Status

Sepraspray Adhesion Barrier – Product Description

HydroGlaze BV Pipeline Products & Ongoing Clinical Trials Overview

HydroGlaze – Product Status

HydroGlaze – Product Description

Innocoll Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

CM004 – Product Status

CM004 – Product Description

Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

HA Fabric Sheet Adhesive Barrier – Product Status

HA Fabric Sheet Adhesive Barrier – Product Description

HA Film Adhesive Barrier – Product Status

HA Film Adhesive Barrier – Product Description

Wool Adhesive Barrier – Product Status

Wool Adhesive Barrier – Product Description

Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Adhes-X – Product Status

Adhes-X – Product Description

Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview

Rebasol – Product Status

Rebasol – Product Description

Luna Innovations Inc Pipeline Products & Ongoing Clinical Trials Overview

Sutureless Absorbable Antiadhesion Film – Product Status

Sutureless Absorbable Antiadhesion Film – Product Description

TissuCoat – Product Status

TissuCoat – Product Description

Magen OrthoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview

NerveShield – Product Status

NerveShield – Product Description

TendonShield – Product Status

TendonShield – Product Description

Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

MaxiGel – Product Status

MaxiGel – Product Description

Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

FlexiSurge Adhesive Barrier – Product Status

FlexiSurge Adhesive Barrier – Product Description

MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview

Adhesion Barrier – Product Status

Adhesion Barrier – Product Description

Biologic Barrier Membrane – Superficial Wounds – Product Status

Biologic Barrier Membrane – Superficial Wounds – Product Description

PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

Anti-Adhesion Film – Product Status

Anti-Adhesion Film – Product Description

Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview

Biodegradable Film Implant – Product Status

Biodegradable Film Implant – Product Description

Seikagaku Corp Pipeline Products & Ongoing Clinical Trials Overview

SI-449 Adhesion Barrier System – Product Status

SI-449 Adhesion Barrier System – Product Description

Seikagaku Corp – Ongoing Clinical Trials Overview

SI-449 Adhesion Barrier System – A Randomized, Controlled, Pivotal Study of SI-449 Adhesion Barrier in Patients with Temporary Ileostomy

Sporogenics Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

Anti-Adhesion Barrier Film – Product Status

Anti-Adhesion Barrier Film – Product Description

Microgel Agent – Product Status

Microgel Agent – Product Description

Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview

Bioabsorbable Membrane – Post-Operative Adhesions – Product Status

Bioabsorbable Membrane – Post-Operative Adhesions – Product Description

Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Adhesion Barrier – Product Status

Adhesion Barrier – Product Description

Tribos LLC Pipeline Products & Ongoing Clinical Trials Overview

Lubricin – Surgical Adhesions – Product Status

Lubricin – Surgical Adhesions – Product Description

TYBR Health Inc Pipeline Products & Ongoing Clinical Trials Overview

TYBR Spray – Product Status

TYBR Spray – Product Description

University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview

Photo-Crosslinkable Nano-Patch – Product Status

Photo-Crosslinkable Nano-Patch – Product Description

Glossary

Figures

Surgical Adhesion Barriers – Pipeline Products by Stage of Development

Surgical Adhesion Barriers – Pipeline Products by Segment

Surgical Adhesion Barriers – Pipeline Products by Territory

Surgical Adhesion Barriers – Pipeline Products by Regulatory Path

Surgical Adhesion Barriers – Pipeline Products by Estimated Approval Date

Surgical Adhesion Barriers – Ongoing Clinical Trials

Frequently asked questions

Surgical Adhesion Barriers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Surgical Adhesion Barriers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Surgical Adhesion Barriers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Surgical Adhesion Barriers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.